Iovance Biotherapeutics targets significant market expansion, with lung cancer representing a $10B U.S. peak sales ...
Inhibrx Biosciences Inc. (NASDAQ:INBX) is one of the best emerging technology stocks to invest in. On December 16, Inhibrx ...
Doctors and researchers warn that oesophageal cancer remains one of Kenya’s deadliest malignancies due to late diagnosis and ...
David Swanson started his photography career as a high schooler covering spot news for The York Dispatch and the York Daily ...
In vitro studies pinpoint signaling pathways that could be potential targets in oral squamous cell carcinoma treatments.
The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...
Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...
Peptidream Inc. has announced a new radiopharmaceutical candidate targeting cadherin-3 (CDH3) for the diagnosis and treatment of head and neck squamous cell carcinoma.
Singer-songwriter Barry Manilow shared that he has been diagnosed with lung cancer, noting that it was a “miracle” to have ...
Sense of smell in patients with head and neck cancer began to deteriorate at a radiation dose of 22 Gy and increased in a ...
TipRanks on MSN
Incyte announces approval of Zynyz combination in Japan
Incyte (INCY) announced the Japan Ministry of Health, Labour and Welfare approval of Zynyz in combination with carboplatin and paclitaxel for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results